MIRA Pharmaceuticals, Inc. (MIRA)
USD 1.05
(-1.87%)
USD 1.05
(-1.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -4532.40 | -5.6 Million | -1.37 Million | -203.98 |
| Net Income | -11.98 Thousand | -7.05 Million | -2.17 Million | -203.98 |
| Depreciation & Amortization | 732.29 | - | - | - |
| Deferred income taxes | 401.38 Thousand | - | - | - |
| Stock-based compensation | 2550.95 | 1.29 Million | - | - |
| Change in working capital | 849.93 | 146.58 Thousand | 776 Thousand | - |
| Other non-cash items | 3316.77 | 10.25 Thousand | 24.37 Thousand | - |
| Investing Cash Flow | - | - | - | - |
| Investments in PPE | -1.00 | - | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | 8783.99 | 3.14 Million | 4.18 Million | 213.36 |
| Debt repayment | -2.1 Million | -160 Thousand | -203.06 Thousand | -90 Thousand |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 7.7 Million | 2.9 Million | 4.5 Million | - |
| Other Financing Activities | 8783.99 | 402.18 Thousand | -114.72 Thousand | 213.36 |
| Accounts receivables | -11.86 | - | - | - |
| Accounts payables | -389.52 Thousand | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | 861.79 | 146.58 Thousand | 776 Thousand | - |
| Cash at beginning of period | 350.98 | 2.8 Million | 3491.00 | 364.00 |
| Cash at end of period | 4602.57 | 350.97 Thousand | 2.8 Million | 3491.00 |
| Capital Expenditure | -1.00 | - | - | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 4251.59 | -2.45 Million | 2.8 Million | 3127.00 |
| Free Cash Flow | -4533.40 | -5.6 Million | -1.37 Million | -203.98 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.69 Million | -1.71 Million | -11.98 Million | -5.78 Million | -3.58 Million | -1.26 Million |
| Depreciation & Amortization | - | - | 732.29 Thousand | 732.29 Thousand | - | - |
| Deferred income taxes | - | - | 401.38 Thousand | - | - | - |
| Stock-based compensation | 604.8 Thousand | 500.21 Thousand | 2550.95 | 213.81 | 1.45 Million | 737.2 Thousand |
| Change in working capital | 222.59 Thousand | 168.02 Thousand | -639.68 Thousand | -288.35 Thousand | -39.82 Thousand | -427.79 Thousand |
| Other non-cash items | 458.92 Thousand | 390.65 Thousand | 7.39 Million | 4.18 Million | 414.23 Thousand | 295.88 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 159.01 Thousand | -24.33 Thousand | 9.88 Million | 869.34 Thousand | 7.6 Million | 684.28 Thousand |
| Debt repayment | - | - | -2.1 Million | -2.23 Million | - | -219.54 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1350.10 | - | - |
| Common Stock Issuance | - | - | 7.7 Million | -1.35 Million | 9.05 Million | -163.68 Thousand |
| Other Financing Activities | 159.01 Thousand | -24.33 Thousand | 74.27 Thousand | -19.15 Thousand | -1.44 Million | 1.06 Million |
| Accounts receivables | - | 11.86 Thousand | -11.86 Thousand | -11.86 | - | - |
| Accounts payables | 145.87 Thousand | 97.69 Thousand | -389.52 Thousand | -241 Thousand | - | - |
| Inventory | - | - | - | -11.85 Thousand | - | - |
| Other working capital | 76.71 Thousand | 58.46 Thousand | -238.3 Thousand | -35.48 Thousand | -39.82 Thousand | -427.79 Thousand |
| Cash at beginning of period | 3.52 Million | 4.6 Million | 350.97 Thousand | 5.86 Million | 24.82 Thousand | 1349.00 |
| Cash at end of period | 2.82 Million | 3.52 Million | 4.6 Million | 4.6 Million | 5.86 Million | 24.82 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -704.91 Thousand | -1.07 Million | 4.25 Million | -1.26 Million | 5.84 Million | 23.47 Thousand |
| Free Cash Flow | -863.92 Thousand | -1.04 Million | -5.63 Million | -2.13 Million | -1.76 Million | -660.81 Thousand |
300234
ETP
CLDT-PA
SPACEINCUBA
AMMN
MFC